Skip to main content

Cell Bank Preparation and Characterization

  • Protocol
Animal Cell Biotechnology

Part of the book series: Methods in Biotechnology™ ((MIBT,volume 8))

Abstract

One or more properties of a cell line are likely to change during an extended period of continuous passage. In order to ensure consistency of the properties of a cell line or of a product derived from it, it is, therefore, necessary to cryopreserve and characterize a reference stock of cells. Thereafter, throughout a research, development, or manufacturing program cell cultures are discarded after a defined passage interval and the cryopreserved stock used to reinitiate fresh cultures. Although a small number of ampoules in a single bank may be sufficient for a small research program, to ensure continuity of supply of a cell line from a culture collection or for the manufacture of a biopharmaceutical, it is usual to prepare a two-tiered cell bank system. This consists of a master cell bank (MCB) of 50–400 ampoules and manufacturer’s working cell banks (WCB) each derived in an identical manner from one ampoule of the MCB (Table 1). In this chapter the methods of preparation, storage, and characterization of such cell banks are described.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hay, R. J. (1996) Animal cells in culture, in Maintaining Cultures for Biotechnology and Industry (Hunter-Cevera, J. C. and Belt, A., eds.), Academic Press, London, pp. 161–178.

    Chapter  Google Scholar 

  2. Merten, O.W., Petres, S., and Couvé, E. (1995) A simple serum-free freezing medium for serum-free cultured cells. Biologicals 23:2, 185–189.

    Article  CAS  Google Scholar 

  3. Doyle, A. and Morris, C. B. (1994) Cryopreservation, in Cell & Tissue Culture: Laboratory Procedures (Doyle, A., Griffiths, J. B., and Newell, D. G., eds.), Wiley, Chichester, U.K., pp. 4C:1.1–4C:1.7.

    Google Scholar 

  4. Quality of biotechnological products: derivation and characterization of cell substrates for the production of biotechnological/biological products (1997) ICH, London.

    Google Scholar 

  5. Points to consider in the characterization of cell lines used to produce biologicals (1993) CBER, FDA, Washington, DC.

    Google Scholar 

  6. Production and quality control of monoclonal antibodies (1994) European Commission, Brussels.

    Google Scholar 

  7. Requirements for use of animal cells as in vitro substrates for the production of biologicals (1997) WHO, Geneva.

    Google Scholar 

  8. Tedder, R. S., Zuckerman, M. A., Goldstone, A. H., Hawkins, A. E., Fielding, A., Briggs, E. M., et al. (1995) Hepatitis B transmission from contaminated cryopreservation tank. Lancet 346, 137–140.

    Article  CAS  Google Scholar 

  9. Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin (1997) ICH, London.

    Google Scholar 

  10. Points to consider in the manufacture and testing of monoclonal antibody products for human use (1997) CBER, FDA, Washington.

    Google Scholar 

  11. Böedeker, B. G. D., Newcomb, R., Yuan, P., Braufman, A., and Kelsey, W. (1994) Production of recombinant factor VIII from perfusion cultures: I. Large-scale fermentation, in Animal Cell Technology: Products of Today, Prospects for Tomorrow (Spier, R. E., Griffiths, J. B., and Berthold, W., eds.), Butterworth-Heinemann, Oxford, pp. 580–583.

    Google Scholar 

  12. Froud, S. J., Birch, J., Mclean, C., Shepherd, A. J., and Smith, K. T. (1997) Viral contaminants found in mammalian cell lines used in the production of biological products, in Animal Cell Technology: From Vaccines to Genetic Medicine (Carrondo, M. J. T., Griffiths, B., and Moreira, J. L. P, eds.), Kluwer, Dordrecht, pp. 681–686.

    Google Scholar 

  13. Bebbington, C. R., Renner, G., Thomson, S., King, D., Abrams, D., and Yarranton, G. T. (1992) High level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Bio/technology 10, 169–175.

    Article  CAS  Google Scholar 

  14. Code of Federal Regulations 21, 610.12, FDA, Washington, DC.

    Google Scholar 

  15. Wiebe, M. E., Becker, F., Lazar, R., May, L., Casto, B., Semense, M., et al. (1989) A multifaceted approach to assure that recombinant tPA is free of adventitious virus, in Advances in Animal Cell Biology and Technology for Processes (Spier, R. E., Griffiths, J. B., Stephenne, J., and Crooy, P. J., eds.), Butterworths, Oxford, pp. 68–71.

    Google Scholar 

  16. Quality of biotechnological products: analysis of the expression construct in cells used for production of r-DNA derived protein products (1995) ICH, London.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Humana Press Inc., Totowa, NJ

About this protocol

Cite this protocol

Froud, S.J. (1999). Cell Bank Preparation and Characterization. In: Jenkins, N. (eds) Animal Cell Biotechnology. Methods in Biotechnology™, vol 8. Humana Press. https://doi.org/10.1385/0-89603-547-6:99

Download citation

  • DOI: https://doi.org/10.1385/0-89603-547-6:99

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-547-8

  • Online ISBN: 978-1-59259-486-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics